(Total Views: 524)
Posted On: 07/01/2023 12:45:12 PM
Post# of 153930
$2.90 billion
Provention (PRVB) Skyrockets 260% on Buyout Offer From Sanofi. Shares of Provention Bio PRVB were up 260% on Mar 13 after the company announced that it has signed a definitive agreement with Sanofi SNY. Provention would be acquired by Sanofi for $25 per share in cash, amounting to $2.90 billion
Provention (PRVB) Skyrockets 260% on Buyout Offer From Sanofi. Shares of Provention Bio PRVB were up 260% on Mar 13 after the company announced that it has signed a definitive agreement with Sanofi SNY. Provention would be acquired by Sanofi for $25 per share in cash, amounting to $2.90 billion
(3)
(0)
